4//SEC Filing
BARKER DAVID L 4
Accession 0001411690-22-000016
CIK 0001411690other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:51 PM ET
Size
7.3 KB
Accession
0001411690-22-000016
Insider Transaction Report
Form 4
BARKER DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2022-07-07$0.51/sh+44,470$22,680→ 58,364 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-07-07−44,470→ 0 totalExercise: $0.51Exp: 2030-06-30→ Common Stock (44,470 underlying)
Footnotes (2)
- [F1]The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
- [F2]The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.
Documents
Issuer
Bionano Genomics, Inc.
CIK 0001411690
Entity typeother
Related Parties
1- filerCIK 0001189124
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:51 PM ET
- Size
- 7.3 KB